診断用ラジオアイソトープの世界市場レポート 2025年

診断用ラジオアイソトープ市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR9.7％で88億3,000万米ドルに成長します。予測期間の成長は、新たな放射性同位体製造法、臨床応用の拡大、患者中心のケアと安全性、ポイント・オブ・ケア画像診断、環境持続可能性とグリーンケミストリーに起因すると考えられます。予測期間の主な動向には、ハイブリッドイメージング技術、セラノスティクス、分子イメージング技術、サイクロトロンまたはジェネレーターの使用、安全性と放射線防護などが含まれます。

がんの負担増が診断用ラジオアイソトープ市場の拡大を牽引すると予想されます。がんは、周囲の組織を損傷する異常細胞の無秩序な分裂を特徴とする疾患です。がんの有病率の増加は、喫煙、肥満、運動不足などのライフスタイルの選択、発がん物質への曝露、遺伝的要因、環境の影響など、さまざまな要因に起因しています。放射性同位元素は、正確な診断を提供し、的を絞った治療を可能にし、がんの進行や治療に対する反応を効果的にモニタリングすることを容易にすることで、がん管理において重要な役割を果たしています。例えば、2024年5月、米国を拠点とし、がんの研究およびトレーニングに重点を置く政府機関である国立がん研究所は、2040年までに世界の年間新規がん患者数は2,990万人に達し、がんに関連した死亡者数は1,530万人になると予測しています。その結果、がんの負担増が診断用ラジオアイソトープ市場の成長を牽引しています。

診断用ラジオアイソトープ市場の主要企業は、診断精度の向上、患者の転帰の改善、ヘルスケアにおける核医学の応用拡大に向けて、放射性医薬品技術の進歩に注力しています。先進的な放射性医薬品技術には、核医学における正確なイメージングと標的治療のための革新的な化合物と技術の開発が含まれます。例えば、イタリアの画像診断会社であるブラッコ・グループは、2022年3月に次世代治療用放射性医薬品技術の開発を専門とする子会社ブルー・アース・セラピューティクスを立ち上げ、当初は前立腺がんをターゲットとし、他のがん領域へのさらなる拡大を計画しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、コロナ禍、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界診断用ラジオアイソトープ PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の診断用ラジオアイソトープ市場：成長率分析
• 世界の診断用ラジオアイソトープ市場の実績：規模と成長, 2019-2024
• 世界の診断用ラジオアイソトープ市場の予測：規模と成長, 2024-2029, 2034F
• 世界診断用ラジオアイソトープ総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の診断用ラジオアイソトープ市場放射性同位元素による、実績と予測, 2019-2024, 2024-2029F, 2034F
• テクネチウム99m
• タリウム201
• ガリウム67
• ヨウ素123
• フルオロデオキシグルコース（FDG）
• ルビジウム82
• その他の放射性同位元素
• 世界の診断用ラジオアイソトープ市場画像診断法別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 単一光子放出コンピュータ断層撮影（SPECT）
• 陽電子放出断層撮影（PET）
• ベータ線放射体
• 世界の診断用ラジオアイソトープ市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 腫瘍学
• 心臓病学
• その他の用途
• 世界の診断用ラジオアイソトープ市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 専門クリニック
• 診断センター
• 学術研究機関
• その他のエンドユーザー
• 世界の診断用ラジオアイソトープ市場テクネチウム99mの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 診断画像
• 心臓画像
• 腫瘍画像診断
• 骨スキャン
• 腎臓スキャン
• 世界の診断用ラジオアイソトープ市場タリウム201の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 心臓画像
• 心筋血流イメージング
• ストレステスト
• 世界の診断用ラジオアイソトープ市場、ガリウム67のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 腫瘍画像診断（リンパ腫、腫瘍）
• 炎症性疾患の画像診断
• 感染画像診断
• 世界の診断用ラジオアイソトープ市場ヨウ素123の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 甲状腺画像検査
• 神経学的画像検査（パーキンソン病）
• 心臓画像
• 世界の診断用ラジオアイソトープ市場、フルオロデオキシグルコース（FDG）の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 陽電子放出断層撮影（PET）画像
• がんの診断とステージング
• 神経画像
• 心臓画像
• 世界の診断用ラジオアイソトープ市場ルビジウム82の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 心臓PET画像
• 心筋血流イメージング
• 冠動脈疾患の診断
• 世界の診断用ラジオアイソトープ市場その他の放射性同位元素の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• ストロンチウム89（骨痛緩和）
• ヨウ素131（甲状腺がんの治療）
• サマリウム153（骨痛緩和）
• イットリウム90（がん治療）

第7章 地域別・国別分析

• 世界の診断用ラジオアイソトープ市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の診断用ラジオアイソトープ市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 診断用ラジオアイソトープ市場：競合情勢
• 診断用ラジオアイソトープ市場：企業プロファイル
  • Cardinal Health Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Sumitomo Heavy Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • BWX Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Lantheus Holdings Overview, Products and Services, Strategy and Financial Analysis
  • Curium Pharma Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Clarity Pharmaceuticals
• Bracco Diagnostic Inc.
• Ion Beam Applications S.A.
• Nordion Inc.
• Eckert & Ziegler AG
• NorthStar Medical Radioisotopes LLC
• NTP Radioisotopes SOC Ltd
• Global Medical Solutions Ltd.
• Isotopia Molecular Imaging Ltd.
• Cyclopharm Limited
• Trasis NV
• Orano Med LLC
• ARTMS Inc.
• Radiomedix Inc.
• Coqu RadioPharmaceuticals Corp.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 診断用ラジオアイソトープ市場2029：新たな機会を提供する国
• 診断用ラジオアイソトープ市場2029：新たな機会を提供するセグメント
• 診断用ラジオアイソトープ市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Diagnostic radioisotopes are radioactive isotopes employed in nuclear medicine for diagnosing and monitoring diverse medical conditions. They rely on their radioactive decay characteristics to emit radiation, detected by specialized imaging tools, enabling healthcare providers to acquire detailed internal body structure images and evaluate their function.

The primary diagnostic radioisotopes include technetium-99m, thallium-201, gallium-67, iodine-123, fluorodeoxyglucose (FDG), rubidium-82, and others. Technetium-99m is extensively used in medical imaging due to its advantageous nuclear properties and wide accessibility. Imaging techniques include single photon emission computed tomography (SPECT), positron emission tomography (PET), and beta emitters, employed across various fields such as oncology and cardiology.

The diagnostic radioisotopes research report is one of a series of new reports from The Business Research Company that provides diagnostic radioisotopes market statistics, including the diagnostic radioisotopes industry's global market size, regional shares, competitors with a diagnostic radioisotopes market share, detailed diagnostic radioisotopes market segments, market trends and opportunities, and any further data you may need to thrive in the diagnostic radioisotopes industry. This diagnostic radioisotopes market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The diagnostic radioisotopes market size has grown rapidly in recent years. It will grow from $5.54 billion in 2024 to $6.1 billion in 2025 at a compound annual growth rate (CAGR) of 10.0%. The growth in the historic period can be attributed to the discovery of radioactivity, the introduction of technetium-99m, clinical applications and research, cold war era and nuclear research, and emergence of positron emission tomography.

The diagnostic radioisotopes market size is expected to see strong growth in the next few years. It will grow to $8.83 billion in 2029 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to emerging radioisotope production methods, expanded clinical applications, patient-centered care and safety, point-of-care imaging and environmental sustainability and green chemistry. Major trends in the forecast period include hybrid imaging techniques, theranostics, molecular imaging techniques, the use of cyclotrons or generators, and safety and radiation protection.

The growing burden of cancer is expected to drive the expansion of the diagnostic radioisotopes market. Cancer is a disease characterized by the uncontrolled division of abnormal cells that damage surrounding tissue. The increasing prevalence of cancer is attributed to various factors, including lifestyle choices such as smoking, obesity, lack of physical activity, exposure to carcinogens, genetic factors, and environmental influences. Radioisotopes play a crucial role in cancer management by providing accurate diagnosis, enabling targeted treatments, and facilitating effective monitoring of cancer progression or response to therapy. For example, in May 2024, the National Cancer Institute, a US-based government agency focused on cancer research and training, projected that by 2040, the global number of new cancer cases per year will reach 29.9 million, with 15.3 million cancer-related deaths. As a result, the rising burden of cancer is driving the growth of the diagnostic radioisotopes market.

Key players in the diagnostic radioisotopes market are focused on advancing radiopharmaceutical technology to enhance diagnostic accuracy, improve patient outcomes, and expand the applications of nuclear medicine in healthcare. Advanced radiopharmaceutical technology involves the development of innovative compounds and techniques for precise imaging and targeted therapy in nuclear medicine. For example, Bracco Group, an Italy-based diagnostic imaging company, launched Blue Earth Therapeutics in March 2022, a subsidiary dedicated to advancing next-generation therapeutic radiopharmaceutical technology, initially targeting prostate cancer with plans for further expansion into other oncology areas.

In April 2024, Telix Pharmaceuticals Limited, an Australia-based biotechnology company, acquired ARTMS to strengthen its supply chain and manufacturing capabilities. This acquisition aims to leverage ARTMS' expertise in cyclotron-based isotope production to enhance market position and meet the growing demand for diagnostic and therapeutic isotopes. ARTMS, headquartered in Canada, specializes in radioisotope technology and is a leading provider of diagnostic radioisotopes.

Major companies operating in the diagnostic radioisotopes market are Cardinal Health Inc., Sumitomo Heavy Industries Ltd., BWX Technologies Inc., Lantheus Holdings, Curium Pharma, Clarity Pharmaceuticals, Bracco Diagnostic Inc., Ion Beam Applications S.A., Nordion Inc., Eckert & Ziegler AG, NorthStar Medical Radioisotopes LLC, NTP Radioisotopes SOC Ltd, Global Medical Solutions Ltd., Isotopia Molecular Imaging Ltd., Cyclopharm Limited, Trasis NV, Orano Med LLC, ARTMS Inc., Radiomedix Inc., Coqu RadioPharmaceuticals Corp., IsoTherapeutics Group LLC

North America was the largest region in the diagnostic radioisotopes market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the diagnostic radioisotopes market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the diagnostic radioisotopes market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The diagnostic radioisotopes market consists of revenues earned by entities by providing services such as radiopharmacy services, imaging services, radioisotope production and supply, diagnostic procedures, and theranostics. The market value includes the value of related goods sold by the service provider or included within the service offering. The diagnostic radioisotopes market also includes sales of products including Indium-111, Xenon-133, Molybdenum-99, and Phosphorus-32. Values in this market are 'factory gate values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Diagnostic Radioisotopes Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on diagnostic radioisotopes market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for diagnostic radioisotopes ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The diagnostic radioisotopes market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Radioisotope: Technetium-99m; Thallium-201; Gallium-67; Iodine-123; FluoroDeoxyGlucose (FDG); Rubidium-82; Other Radioisotopes
• 2) By Imaging Modality: Single Photon Emission Computed Tomography (SPECT); Positron Emission Tomography (PET); Beta Emitters
• 3) By Application: Oncology; Cardiology; Other Applications
• 4) By End User: Hospitals; Specialty Clinics; Diagnostic Centers; Academic And Research Institutes; Other End Users
• Subsegments:
• 1) By Technetium-99m: Diagnostic Imaging; Cardiac Imaging; Oncology Imaging; Bone Scans; Renal Scans
• 2) By Thallium-201: Cardiac Imaging; Myocardial Perfusion Imaging; Stress Tests
• 3) By Gallium-67: Oncology Imaging (Lymphoma, Tumors); Inflammatory Disease Imaging; Infection Imaging
• 4) By Iodine-123: Thyroid Imaging; Neurological Imaging (Parkinson's Disease); Cardiac Imaging
• 5) By FluoroDeoxyGlucose (FDG): Positron Emission Tomography (PET) Imaging; Cancer Diagnosis And Staging; Neurological Imaging; Cardiac Imaging
• 6) By Rubidium-82: Cardiac PET Imaging; Myocardial Perfusion Imaging; Coronary Artery Disease Diagnosis
• 7) By Other Radioisotopes: Strontium-89 (Bone Pain Palliation); Iodine-131 (Thyroid Cancer Treatment); Samarium-153 (Bone Pain Palliation); Yttrium-90 (Cancer Treatment)
• Companies Mentioned: Cardinal Health Inc.; Sumitomo Heavy Industries Ltd.; BWX Technologies Inc.; Lantheus Holdings; Curium Pharma
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Diagnostic Radioisotopes market Characteristics

3. Diagnostic Radioisotopes market Trends And Strategies

4. Diagnostic Radioisotopes market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Diagnostic Radioisotopes Growth Analysis And Strategic Analysis Framework

• 5.1. Global Diagnostic Radioisotopes PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Diagnostic Radioisotopes market Growth Rate Analysis
• 5.4. Global Diagnostic Radioisotopes Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Diagnostic Radioisotopes Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Diagnostic Radioisotopes Total Addressable Market (TAM)

6. Diagnostic Radioisotopes market Segmentation

• 6.1. Global Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Technetium-99m
• Thallium-201
• Gallium-67
• Iodine-123
• FluoroDeoxyGlucose (FDG)
• Rubidium-82
• Other Radioisotopes
• 6.2. Global Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Single Photon Emission Computed Tomography (SPECT)
• Positron Emission Tomography (PET)
• Beta Emitters
• 6.3. Global Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oncology
• Cardiology
• Other Applications
• 6.4. Global Diagnostic Radioisotopes market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Specialty Clinics
• Diagnostic Centers
• Academic And Research Institutes
• Other End Users
• 6.5. Global Diagnostic Radioisotopes Market, Sub-Segmentation Of Technetium-99m, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Diagnostic Imaging
• Cardiac Imaging
• Oncology Imaging
• Bone Scans
• Renal Scans
• 6.6. Global Diagnostic Radioisotopes Market, Sub-Segmentation Of Thallium-201, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cardiac Imaging
• Myocardial Perfusion Imaging
• Stress Tests
• 6.7. Global Diagnostic Radioisotopes Market, Sub-Segmentation Of Gallium-67, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oncology Imaging (Lymphoma, Tumors)
• Inflammatory Disease Imaging
• Infection Imaging
• 6.8. Global Diagnostic Radioisotopes Market, Sub-Segmentation Of Iodine-123, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Thyroid Imaging
• Neurological Imaging (Parkinson's Disease)
• Cardiac Imaging
• 6.9. Global Diagnostic Radioisotopes Market, Sub-Segmentation Of FluoroDeoxyGlucose (FDG), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Positron Emission Tomography (PET) Imaging
• Cancer Diagnosis And Staging
• Neurological Imaging
• Cardiac Imaging
• 6.10. Global Diagnostic Radioisotopes Market, Sub-Segmentation Of Rubidium-82, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cardiac PET Imaging
• Myocardial Perfusion Imaging
• Coronary Artery Disease Diagnosis
• 6.11. Global Diagnostic Radioisotopes Market, Sub-Segmentation Of Other Radioisotopes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Strontium-89 (Bone Pain Palliation)
• Iodine-131 (Thyroid Cancer Treatment)
• Samarium-153 (Bone Pain Palliation)
• Yttrium-90 (Cancer Treatment)

7. Diagnostic Radioisotopes market Regional And Country Analysis

• 7.1. Global Diagnostic Radioisotopes market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Diagnostic Radioisotopes market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Diagnostic Radioisotopes market

• 8.1. Asia-Pacific Diagnostic Radioisotopes market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Diagnostic Radioisotopes market

• 9.1. China Diagnostic Radioisotopes market Overview
• 9.2. China Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Diagnostic Radioisotopes market

• 10.1. India Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Diagnostic Radioisotopes market

• 11.1. Japan Diagnostic Radioisotopes market Overview
• 11.2. Japan Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Diagnostic Radioisotopes market

• 12.1. Australia Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Diagnostic Radioisotopes market

• 13.1. Indonesia Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Diagnostic Radioisotopes market

• 14.1. South Korea Diagnostic Radioisotopes market Overview
• 14.2. South Korea Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Diagnostic Radioisotopes market

• 15.1. Western Europe Diagnostic Radioisotopes market Overview
• 15.2. Western Europe Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Diagnostic Radioisotopes market

• 16.1. UK Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Diagnostic Radioisotopes market

• 17.1. Germany Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Diagnostic Radioisotopes market

• 18.1. France Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Diagnostic Radioisotopes market

• 19.1. Italy Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Diagnostic Radioisotopes market

• 20.1. Spain Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Diagnostic Radioisotopes market

• 21.1. Eastern Europe Diagnostic Radioisotopes market Overview
• 21.2. Eastern Europe Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Diagnostic Radioisotopes market

• 22.1. Russia Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Diagnostic Radioisotopes market

• 23.1. North America Diagnostic Radioisotopes market Overview
• 23.2. North America Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Diagnostic Radioisotopes market

• 24.1. USA Diagnostic Radioisotopes market Overview
• 24.2. USA Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Diagnostic Radioisotopes market

• 25.1. Canada Diagnostic Radioisotopes market Overview
• 25.2. Canada Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Diagnostic Radioisotopes market

• 26.1. South America Diagnostic Radioisotopes market Overview
• 26.2. South America Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Diagnostic Radioisotopes market

• 27.1. Brazil Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Diagnostic Radioisotopes market

• 28.1. Middle East Diagnostic Radioisotopes market Overview
• 28.2. Middle East Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Diagnostic Radioisotopes market

• 29.1. Africa Diagnostic Radioisotopes market Overview
• 29.2. Africa Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Diagnostic Radioisotopes market Competitive Landscape And Company Profiles

• 30.1. Diagnostic Radioisotopes market Competitive Landscape
• 30.2. Diagnostic Radioisotopes market Company Profiles
  • 30.2.1. Cardinal Health Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Sumitomo Heavy Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. BWX Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Lantheus Holdings Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Curium Pharma Overview, Products and Services, Strategy and Financial Analysis

31. Diagnostic Radioisotopes market Other Major And Innovative Companies

• 31.1. Clarity Pharmaceuticals
• 31.2. Bracco Diagnostic Inc.
• 31.3. Ion Beam Applications S.A.
• 31.4. Nordion Inc.
• 31.5. Eckert & Ziegler AG
• 31.6. NorthStar Medical Radioisotopes LLC
• 31.7. NTP Radioisotopes SOC Ltd
• 31.8. Global Medical Solutions Ltd.
• 31.9. Isotopia Molecular Imaging Ltd.
• 31.10. Cyclopharm Limited
• 31.11. Trasis NV
• 31.12. Orano Med LLC
• 31.13. ARTMS Inc.
• 31.14. Radiomedix Inc.
• 31.15. Coqu RadioPharmaceuticals Corp.

32. Global Diagnostic Radioisotopes market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Diagnostic Radioisotopes market

34. Recent Developments In The Diagnostic Radioisotopes market

35. Diagnostic Radioisotopes market High Potential Countries, Segments and Strategies

• 35.1 Diagnostic Radioisotopes market In 2029 - Countries Offering Most New Opportunities
• 35.2 Diagnostic Radioisotopes market In 2029 - Segments Offering Most New Opportunities
• 35.3 Diagnostic Radioisotopes market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer